Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond.

Identifieur interne : 000104 ( 2020/Analysis ); précédent : 000103; suivant : 000105

Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond.

Auteurs : Sean Ekins [États-Unis] ; Thomas R. Lane [États-Unis] ; Peter B. Madrid [États-Unis]

Source :

RBID : pubmed:32215760

Descripteurs français

English descriptors

Abstract

For the last 50 years we have known of a broad-spectrum agent tilorone dihydrochloride (Tilorone). This is a small-molecule orally bioavailable drug that was originally discovered in the USA and is currently used clinically as an antiviral in Russia and the Ukraine. Over the years there have been numerous clinical and non-clinical reports of its broad spectrum of antiviral activity. More recently we have identified additional promising antiviral activities against Middle East Respiratory Syndrome, Chikungunya, Ebola and Marburg which highlights that this old drug may have other uses against new viruses. This may in turn inform the types of drugs that we need for virus outbreaks such as for the new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Tilorone has been long neglected by the west in many respects but it deserves further reassessment in light of current and future needs for broad-spectrum antivirals.

DOI: 10.1007/s11095-020-02799-8
PubMed: 32215760


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:32215760

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond.</title>
<author>
<name sortKey="Ekins, Sean" sort="Ekins, Sean" uniqKey="Ekins S" first="Sean" last="Ekins">Sean Ekins</name>
<affiliation wicri:level="2">
<nlm:affiliation>Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC27606, USA. sean@collaborationspharma.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC27606</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lane, Thomas R" sort="Lane, Thomas R" uniqKey="Lane T" first="Thomas R" last="Lane">Thomas R. Lane</name>
<affiliation wicri:level="2">
<nlm:affiliation>Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC27606, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC27606</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Madrid, Peter B" sort="Madrid, Peter B" uniqKey="Madrid P" first="Peter B" last="Madrid">Peter B. Madrid</name>
<affiliation wicri:level="1">
<nlm:affiliation>SRI International, 333 Ravenswood Avenue, Menlo Park, California, 94025, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>SRI International, 333 Ravenswood Avenue, Menlo Park, California, 94025</wicri:regionArea>
<wicri:noRegion>94025</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32215760</idno>
<idno type="pmid">32215760</idno>
<idno type="doi">10.1007/s11095-020-02799-8</idno>
<idno type="wicri:Area/PubMed/Corpus">000505</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000505</idno>
<idno type="wicri:Area/PubMed/Curation">000505</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000505</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000086</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000086</idno>
<idno type="wicri:Area/Ncbi/Merge">003557</idno>
<idno type="wicri:Area/Ncbi/Curation">003557</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003557</idno>
<idno type="wicri:Area/Main/Merge">000104</idno>
<idno type="wicri:Area/Main/Curation">000104</idno>
<idno type="wicri:Area/Main/Exploration">000104</idno>
<idno type="wicri:Area/2020/Extraction">000104</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond.</title>
<author>
<name sortKey="Ekins, Sean" sort="Ekins, Sean" uniqKey="Ekins S" first="Sean" last="Ekins">Sean Ekins</name>
<affiliation wicri:level="2">
<nlm:affiliation>Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC27606, USA. sean@collaborationspharma.com.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC27606</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lane, Thomas R" sort="Lane, Thomas R" uniqKey="Lane T" first="Thomas R" last="Lane">Thomas R. Lane</name>
<affiliation wicri:level="2">
<nlm:affiliation>Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC27606, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC27606</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Madrid, Peter B" sort="Madrid, Peter B" uniqKey="Madrid P" first="Peter B" last="Madrid">Peter B. Madrid</name>
<affiliation wicri:level="1">
<nlm:affiliation>SRI International, 333 Ravenswood Avenue, Menlo Park, California, 94025, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>SRI International, 333 Ravenswood Avenue, Menlo Park, California, 94025</wicri:regionArea>
<wicri:noRegion>94025</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Pharmaceutical research</title>
<idno type="eISSN">1573-904X</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Betacoronavirus (drug effects)</term>
<term>Chikungunya virus (drug effects)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Ebolavirus (drug effects)</term>
<term>Humans</term>
<term>Marburgvirus (drug effects)</term>
<term>Middle East Respiratory Syndrome Coronavirus (drug effects)</term>
<term>Pandemics</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Tilorone (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Antiviraux (pharmacologie)</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient ()</term>
<term>Ebolavirus ()</term>
<term>Humains</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Marburgvirus ()</term>
<term>Pandémies</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Tilorone (pharmacologie)</term>
<term>Virus du chikungunya ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antiviral Agents</term>
<term>Tilorone</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Betacoronavirus</term>
<term>Chikungunya virus</term>
<term>Ebolavirus</term>
<term>Marburgvirus</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antiviraux</term>
<term>Tilorone</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Ebolavirus</term>
<term>Humains</term>
<term>Marburgvirus</term>
<term>Pandémies</term>
<term>Virus du chikungunya</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">For the last 50 years we have known of a broad-spectrum agent tilorone dihydrochloride (Tilorone). This is a small-molecule orally bioavailable drug that was originally discovered in the USA and is currently used clinically as an antiviral in Russia and the Ukraine. Over the years there have been numerous clinical and non-clinical reports of its broad spectrum of antiviral activity. More recently we have identified additional promising antiviral activities against Middle East Respiratory Syndrome, Chikungunya, Ebola and Marburg which highlights that this old drug may have other uses against new viruses. This may in turn inform the types of drugs that we need for virus outbreaks such as for the new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Tilorone has been long neglected by the west in many respects but it deserves further reassessment in light of current and future needs for broad-spectrum antivirals.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Caroline du Nord</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Caroline du Nord">
<name sortKey="Ekins, Sean" sort="Ekins, Sean" uniqKey="Ekins S" first="Sean" last="Ekins">Sean Ekins</name>
</region>
<name sortKey="Lane, Thomas R" sort="Lane, Thomas R" uniqKey="Lane T" first="Thomas R" last="Lane">Thomas R. Lane</name>
<name sortKey="Madrid, Peter B" sort="Madrid, Peter B" uniqKey="Madrid P" first="Peter B" last="Madrid">Peter B. Madrid</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000104 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000104 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:32215760
   |texte=   Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i   -Sk "pubmed:32215760" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021